Portfolio

Solasta Bio

CEO Professor Shireen Davies, PhD FRSE

Solasta Bio is a Glasgow-based agri-ciotechnology company founded in 2020.

The company has developed a unique peptide-based platform that enables the production of nature-inspred bioinsecticides - a first of its kind. Unlike traditional synthetic chemicals, these neuropeptide-based insect control agents (ICAs) specifically target pest insects while remaining harmless to pollinators, humans, wildlife, and the borarder environment.

Planetary Health

Solasta Bio

UK

SOLASTA Bio Ltd.
C/O Davidson Chalmers Stewart
163 Bath Street
Glasgow, G2 4SQ

Industry

Biotech

Status

Current

Location

UK

Image of cloudy sky surrounded by circle of trees
For globally sustainable crop protection and food production, SOLASTA Bio is developing disruptive small peptide technology against major insect crop pests, via our state-of-the-art rapid discovery platform. Excitingly, SOLASTA's small peptides have demonstrated field trial efficacy on par with commercial standards against several insect pests and crops across global territories, and are now being scaled up to production volumes. In addition to their key investment, Forbion Bioeconomy's deep industry and stakeholder connections have greatly helped SOLASTA in rapidly achieving a significant manufacturing route milestone, increasing our competitiveness and value in the market.

Shireen Davies

CEO of Solasta Bio

Shireen Davies, CEO Of Solasta Bio

$14m

Series A financing